Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-02-17

FDA Approved: VALPROATE SODIUM — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved the original ANDA for valproate sodium, a generic anticonvulsant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALPROATE SODIUM (VALPROATE SODIUM)

Snippet

ORIG AP for VALPROATE SODIUM (VALPROATE SODIUM)